Pei G, Samama P, Lohse M, Wang M, Codina J, Lefkowitz R J
Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710.
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2699-702. doi: 10.1073/pnas.91.7.2699.
The beta 2-adrenergic receptor (beta 2AR) can be constitutively activated by mutations in the third intracellular loop. Whereas the wild-type receptor exists predominantly in an inactive conformation (R) in the absence of agonist, the mutant receptor appears to spontaneously adopt an active conformation (R*). We now demonstrate that not only is the mutant beta 2AR constitutively active, it is also constitutively desensitized and down-regulated. To assess whether the mutant receptor can constitutively engage a known element of the cellular desensitization machinery, the receptor was purified and reconstituted into phospholipid vesicles. These preparations retained the essential properties of the constitutively active mutant receptor: agonist-independent activity [to stimulate guanine nucleotide-binding protein (Gs)-GTPase] and agonist-specific increase in binding affinity. Moreover, the purified mutant receptor, in the absence of agonist, was phosphorylated by recombinant beta AR-specific kinase (beta ARK) in a fashion comparable to the agonist-occupied wild-type receptor. Thus, the conformation of the mutated receptor is equivalent to the active conformation (R*), which stimulates Gs protein and is identical to the beta ARK substrate.
β2 -肾上腺素能受体(β2AR)可因第三细胞内环的突变而组成性激活。在没有激动剂的情况下,野生型受体主要以无活性构象(R)存在,而突变型受体似乎会自发地采用活性构象(R*)。我们现在证明,突变型β2AR不仅组成性激活,还组成性脱敏和下调。为了评估突变型受体是否能组成性地参与细胞脱敏机制的已知元件,将该受体纯化并重构到磷脂囊泡中。这些制剂保留了组成性激活的突变型受体的基本特性:不依赖激动剂的活性[刺激鸟嘌呤核苷酸结合蛋白(Gs)-GTP酶]和激动剂特异性结合亲和力增加。此外,纯化的突变型受体在没有激动剂的情况下,被重组βAR特异性激酶(βARK)磷酸化,其方式与被激动剂占据的野生型受体相当。因此,突变型受体的构象等同于活性构象(R*),它刺激Gs蛋白,并且与βARK底物相同。